| Tau pathology and neurodegeneration | 2013/06/01 | English | 29 |
| Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment | 2009/05/01 | English | 29 |
| Neuroinflammation in Parkinson's disease: a target for neuroprotection? | 2009/04/01 | English | 28 |
| Tinnitus: causes and clinical management | 2013/09/01 | English | 28 |
| Neuropathology of patients with COVID-19 in Germany: a post-mortem case series | 2020/11/01 | English | 28 |
| Dystrophin and mutations: one gene, several proteins, multiple phenotypes | 2003/12/01 | English | 28 |
| Dementia in China: epidemiology, clinical management, and research advances | 2020/01/01 | English | 27 |
| Vascular cognitive impairment | 2003/02/01 | English | 27 |
| Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes | 2008/10/01 | English | 27 |
| Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management | 2018/03/01 | English | 26 |
| Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies | 2014/01/01 | English | 26 |
| Huntington's disease: from molecular pathogenesis to clinical treatment | 2011/01/01 | English | 25 |
| Challenges in the diagnosis of Parkinson's disease | 2021/05/01 | English | 25 |
| Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria | 2023/03/01 | English | 25 |
| Moyamoya disease: current concepts and future perspectives | 2008/11/01 | English | 25 |
| Embolic strokes of undetermined source: the case for a new clinical construct | 2014/04/01 | English | 24 |
| The characterisation of subjective cognitive decline | 2020/03/01 | English | 24 |
| Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions | 2015/09/01 | English | 24 |
| Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study | 2014/02/01 | English | 24 |
| An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models | 2019/11/01 | English | 24 |
| Gastrointestinal dysfunction in Parkinson's disease | 2015/06/01 | English | 23 |
| Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial | 2017/06/01 | English | 23 |
| Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management | 2010/01/01 | English | 23 |
| The gut microbiome in neurological disorders | 2020/02/01 | English | 23 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease | 2021/09/01 | English | 23 |
| Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study | 2008/07/01 | English | 22 |
| Myasthenia gravis: subgroup classification and therapeutic strategies | 2015/10/01 | English | 22 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society | 2016/04/01 | English | 22 |
| Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts | 2020/05/01 | English | 22 |
| Targeting the β secretase BACE1 for Alzheimer's disease therapy | 2014/03/01 | English | 22 |